Skip to main content
. Author manuscript; available in PMC: 2015 Oct 29.
Published in final edited form as: Cancer. 2012 Oct 23;119(5):1106–1112. doi: 10.1002/cncr.27862

Table 2.

Patient Characteristics and tumor response

Characteristics Total patients
n=132
Gender
  Female 54 (41%)
  Male 78 (59%)
Age, years (mean, range) 57 (25–87)
Pre-operative clinical stage
  Stage II 30 (23%)
  Stage III 102 (77%)
Neoadjuvant treatment
  5-FU/RT 52 (39%)
  5-FU/RT and mFOLFOX-6 80 (61%)
Tumor response
  pCR 33 (25%)
  Non-pCR 99 (75%)

5-FU: 5-flourouracil; RT: radiation; mFOLFOX-6: Modified FOLFOX-6; pCR: Pathologic complete response.